MTOR and autosomal dominant polycystic kidney disease: Rapamycin have been shown to be effective in rodent models of autosomal dominant PKD (ADPKD), which is consistent with the findings showing that the PI3K/Akt/mTOR pathway is aberrantly activated in ADPKD [7]–[11].